Trinity Biotech (TRIB) has released an update.
Trinity Biotech shareholders have endorsed key resolutions at their Annual General Meeting, including the reappointment of Grant Thornton as the company’s statutory auditor and the reappointment of Dr. Andrew Omidvar as a director. Additionally, the board has appointed Thomas Lindsay as an interim director to ensure the audit committee maintains its independence. These decisions reflect the ongoing governance and oversight efforts within the company.
For further insights into TRIB stock, check out TipRanks’ Stock Analysis page.
